• 1
    Abramson M, Huang CC. Localization of collagenase in human middle ear cholesteatoma. Laryngoscope 1977;87:771791.
  • 2
    Moriyama H, Honda Y, Huang CC, Abramson M. Bone resorption in cholesteatoma: epithelial-mesenchymal cell interaction and collagenase production. Laryngoscope 1987;97:854859.
  • 3
    Jung TT, Juhn SK. Prostaglandins in human cholesteatoma and granulation tissue. Am J Otol 1988;9:197200.
  • 4
    Cheshire IM, Blight A, Ratcliffe WA, Proofs DW, Heath DA. Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Lancet 1991;338:10411043.
  • 5
    Kurihara A, Toshima M, Yuasa R, Takasaka T. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1α. Ann Otol Rhinol Laryngol 1991;100:989998.
  • 6
    Kakiuchi H, Kinoshita K, Katoh Y, Tabata T. Interleukin-1 of cholesteatomatous keratinocytes. Ann Otol Rhinol Laryngol Suppl 1992;157:3238.
  • 7
    Fujioka O, Huang CC. Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1994;251:199204.
  • 8
    Cheshire IM, Blight A, Ratcliffe WA, Proops DW. In vitro production of parathyroid hormone-related protein by cholesteatoma and normal skin. Clin Otolaryngol Allied Sci 1995;20:448452.
  • 9
    Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L. Role of interleukin-6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 1996;253:152157.
  • 10
    Bujia J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hultner L. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol 1996;253:252255.
  • 11
    Bujia J, Kim C, Boyle D, Hammer C, Firestein G, Kastenbauer E. Quantitative analysis of interleukin-1α gene expression in middle ear cholesteatoma. Laryngoscope 1996;106:217220.
  • 12
    Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 1996;116:451456.
  • 13
    Kim TT, Chen CT, Huang CC. Expression of annexin II in human middle ear cholesteatoma. Otolaryngol Head Neck Surg 1998;118:324328.
  • 14
    Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-a, intercellular adhesion molecule-1, interleukin-1α and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257265.
  • 15
    Hansen T, Unger RE, Gaumann A, et al. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 2001;14:12261231.
  • 16
    Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis fastor-α, and interleukin-1α in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002;23:647652.
  • 17
    Hamzei M, Ventriglia G, Hagnia M, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 2003;113:436442.
  • 18
    Jeong JH, Park CW, Tae K, et al. Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 2006;116:11801184.
  • 19
    Olszewska E, Olszewski S, Borzym-Kluczyk M, Zwierz K. Role of N-acetyl-β-d-hexosaminidase in cholesteatoma tissue. Acta Biochim Pol 2007;54:365370.
  • 20
    Olszewska E, Borzym-Kluczyk M, Olszewski S, Zwierz K. Catabolism of glycoconjugates in chronic otitis media with cholesteatoma. J Investig Med 2007;55:248254.
  • 21
    Fujimura T, Suzuki H, Shimizu T, et al. Pathological alterations of strial capillaries in dominant white spotting W/Wv mice. Hear Res 2005;209:5359.
  • 22
    Ruedi L. Cholesteatosis of the attic. J Laryngol Otol 1958;72:593609.
  • 23
    Chole RA, McGinn, MD, Tinling SP. Pressure-induced bone resorption in the middle ear. Ann Otol Rhinol Laryngol 1985;94:165170.
  • 24
    Wolfman DE, Chole RA. Osteoclast stimulation by positive middle-ear air pressure. Arch Otolaryngol Head Neck Surg 1986;112:10371042.
  • 25
    Orisek BS, Chole RA. Pressure exerted by experimental cholesteatomas. Arch Otolaryngol Head Neck Surg 1987;113:386391.
  • 26
    Huang CC, Yi ZX, Yuan QG, Abramson M. A morphometric study of the effects of pressure on bone resorption in the middle ear of rats. Am J Otol 1990;11:3943.
  • 27
    Walsh TE, Covell WP, Ogura JH. The effect of cholesteatosis on bone. Ann Otol Rhinol Laryngol 1951;60:11001113.
  • 28
    Kaneko Y, Yuasa R, Ise I, et al. Bone destruction due to the rupture of a cholesteatoma sac: a pathogenesis of bone destruction in aural cholesteatoma. Laryngoscope 1980;90:18651870.
  • 29
    Iino Y, Hoshino E, Tomioka S, Takasaka T, Kaneko Y, Yuasa R. Organic acids and anaerobic microorganisms in the contents of the cholesteatoma sac. Ann Otol Rhinol Laryngol 1983;92:9196.
  • 30
    Suzuki C, Ohtani I. Bone destruction resulting from rupture of a cholesteatoma sac: temporal bone pathology. Otol Neurotol 2004;25:674677.
  • 31
    Chen ZF, Darvell BW, Leung VWH. Hydroxyapatite solubility in simple inorganic solutions. Arch Oral Biol 2004;49:359367.
  • 32
    Chan A, Mauro T. Acidification in the epidermis and the role of secretory phospholipases. Dermatoendocrinol 2011;3:8490.
  • 33
    Barbour ME, Parker DM, Allen GC, Jandt KD. Human enamel dissolution in citric acid as a function of pH in the range 2.30<pH <6.30: a nanoindentation study. Eur J Oral Sci 2003;111:258262.
  • 34
    Magalhaes AC, Wiegand A, Rios D, Buzalaf MA, Lussi A. Fluoride in dental erosion. Monogr Oral Sci 2011;22:158170.
  • 35
    Linck G, Petrovic A, Shambaugh GE Jr. Fluoride and calcium content of bone in otosclerotic patients. Arch Otolaryngol 1967;86:412418.
  • 36
    Torrisi L, Foti G, Campisano SU. Fluorine microanalysis in teeth. Clin Mater 1990;5:139145.
  • 37
    Wright CG, Meyerhoff WL. Pathology of otitis media. Ann Otol Rhinol Laryngol Suppl 1994;163:2426.
  • 38
    Gerami H, Naghavi E, Wahabi-Moghadam M, Forghanparast K, Akbar MH. Comparison of preoperative computerized tomography scan imaging of temporal bone with the intra-operative findings in patients undergoing mastoidectomy. Saudi Med J 2009;30:104108.
  • 39
    Barbour ME, Lussi A, Shellis RP. Screening and prediction of erosive potential. Caries Res 2011;45(suppl 1):2432.
  • 40
    O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009;124(suppl 2):R2R4.
  • 41
    Novak N, Baurecht H, Schafer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008;128:14301435.
  • 42
    Kim BE, Leung DY. Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 2012;4:1216.